BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 29/11/2024

Use of Circulating Tumor Deoxyribonucleic Acid for Curative-Intent Solid Tumor Drug Development; Guidance for Industry; Availability

The US Food and Drug Administration (FDA) has released a final guidance for industry on using circulating tumor DNA for curative-intent solid tumor drug development, providing clarity for sponsors planning to use this biomarker in cancer clinical trials.

Source: Federal Register — Food and Drug AdministrationOpen original release →